Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 90
Summary
- Conditions
- Hepatocellular Carcinoma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Study participants underwent CT, MRI, contrast-enhanced ultrasound with perfluorobutane and sulfur hexafluoride. The diagnostic performance will be compared intra-individually.Masking: None (Open Label)Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The investigators would compare the diagnostic performance for HCC at high-risk individuals between each imaging modality.
The investigators would compare the diagnostic performance for HCC at high-risk individuals between each imaging modality.
Tracking Information
- NCT #
- NCT04847726
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jeong Min Lee, Dr. Seoul National University Hospital
Get Well Soon